Sun Pharmaceuticals Industries (BOM:524715) Cash Flow for Dividends : ₹0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Cash Flow for Dividends?

Sun Pharmaceuticals Industries's cash flow for dividends for the three months ended in Dec. 2023 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Sun Pharmaceuticals Industries's annual payment of dividends increased from Mar. 2021 (₹-15,595 Mil) to Mar. 2022 (₹-21,589 Mil) and increased from Mar. 2022 (₹-21,589 Mil) to Mar. 2023 (₹-25,189 Mil).

Sun Pharmaceuticals Industries Cash Flow for Dividends Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Cash Flow for Dividends Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash Flow for Dividends

Get a 7-Day Free Trial

-4,801.80

-13,791.90

-15,594.70

-21,589.20

-25,188.80

Sun Pharmaceuticals Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Sun Pharmaceuticals Industries Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Sun Pharmaceuticals Industries Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (BOM:524715) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Cash Flow for Dividends

Traded in Other Exchanges

SUNPHARMA:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (BOM:524715) Headlines

No Headlines